LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.73 84.90 89 3254 0.0273 0.0090
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.73 84.90 2238 3254 0.6877 0.8626
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.73 84.90 135 3254 0.0415 0.0922
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 36.73 84.90 2647 3254 0.8134 0.9230
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 38.43 84.90 109 3459 0.0315 0.0478
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 38.43 84.90 2402 3459 0.6943 0.8681
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 38.43 84.90 154 3459 0.0445 0.1178
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 38.43 84.90 2862 3459 0.8273 0.9303
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 40.14 84.90 98 3682 0.0266 0.0267
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 40.14 84.90 2519 3682 0.6841 0.8652
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 40.14 84.90 176 3682 0.0478 0.1435
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 40.14 84.90 3059 3682 0.8308 0.9330
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 41.84 84.90 69 4003 0.0172 -0.0366
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 41.84 84.90 2666 4003 0.6660 0.8590
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 41.84 84.90 194 4003 0.0485 0.1603
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 41.84 84.90 3229 4003 0.8066 0.9242
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 43.55 84.90 98 4287 0.0229 0.0257
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 43.55 84.90 2845 4287 0.6635 0.8601
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 43.55 84.90 236 4287 0.0550 0.1980
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 43.55 84.90 3423 4287 0.7983 0.9219
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 45.25 84.90 119 4539 0.0262 0.0606
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 45.25 84.90 3028 4539 0.6670 0.8638
MN20160318_Q02
E17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 45.25 84.90 248 4539 0.0546 0.2053
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 45.25 84.90 3613 4539 0.7958 0.9220
MN20160318_Q02
J17
MCF 10A-H2B-mCherry Dasatinib
0.056667
 46.95 84.90 139 4952 0.0281 0.0877
MN20160318_Q02
E17